WebApr 12, 2024 · Maria Fardis, Ph.D., MBA, has been a venture partner at Frazier Life Sciences since 2024. Dr. Fardis previously served as President and Chief Executive … WebJun 3, 2016 · Dr. Fardis brings extensive experience in novel oncology drug development. Company agrees to $100 million in equity financing led by Quogue Capital, OrbiMed …
CRISPR Therapeutics nominates Dr. Maria Fardis for election to …
WebJan 19, 2024 · "Maria joined our Board in October 2024 and has been instrumental in the Company's preparations for a pivotal 2024," said Paul Wotton, Ph.D., Chief Executive Officer of Obsidian. "Maria pioneered ... WebMay 19, 2024 · Iovance revealed in an SEC filing Wednesday morning that CEO Maria Fardis had informed the board yesterday that she would resign from the company “to pursue other opportunities.” The company... bright horizons goldman sachs
Iovance CEO Resigns Following Regulatory Delay for Melanoma …
WebSep 22, 2024 · MENLO PARK, Calif., September 22, 2024--Frazier Healthcare Partners announced the addition of Maria Fardis, Ph.D. as a Venture Partner on the Life Sciences team. She has over 20 years of scientific and management experience in numerous public and private biopharmaceutical companies. She is also the Chief Executive Officer of … WebApr 12, 2024 · Maria Fardis, Ph.D., MBA, has been a venture partner at Frazier Life Sciences since 2024. Dr. Fardis previously served as President and CEO of Iovance … WebDr. Maria Fardis serves as President, Chief Executive Officer & Board Member at Iovance Biotherapeutics. She serves as Chairman at Lassen Therapeutics. She also serves as Venture Partner at Frazier Healthcare Partners. She served as Board Member at Kartos Therapeutics and Quanta Therapeutics. She has extensive experience in drug … can you erase sharpie from paper